AZA. O. Zhamba

A. O. Zhamba

*This is an algorithmically generated author record based on publicly available information.

A. O. Zhamba has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    АГОНІСТИ РЕЦЕПТОРІВ ГПП-1: ПЕРЕВАГИ ТА РИЗИКИ

    by Інна Дорошкевич, Марина Власенко, Алла Жамба, Святослав Семененко, Анатолій Паламарчук

    Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are actively used for the treatment of type 2 diabetes mellitus and obesity. Since they effectively reduce glycemia, contribute to weight loss and improve the quality of life of patients. Despite the undeniable advantages and expansion of indications for the use of GLP-1 RA, in particular in obese patients without diabetes, there is a growing need for in-depth study of their safety profile. Purpose: to establish the advantages and disadvantages of glucagon-like peptide-1 receptor agonists using based on the analysis of scientific literature. Materials and methods. An analysis of studies in various databases was conducted, in particular Scopus, Web of Science, Google Scholar, PubMed, SpringerLink, reprotox, Medline, Cochrane Library for 2016-2026. The results of randomized clinical trials, meta-analyses and recommendations of leading diabetes associations that evaluated the effects of GLP-1 RA in patients with type 2 diabetes and obesity were analyzed. Results. GLP-1 RA have a high clinical efficacy, combining good glycemic control and significant weight loss, along with proven cardio- and renoprotective effects. Accordingly, these pharmacodynamic effects confirm the extraordinary value of GLP-1 RA in the treatment of common metabolic disorders. However, their use should be based on an individual assessment of the benefits and risks, taking into account comorbidities and individual characteristics of patients. For example, despite the metabolic benefits of obesity and type 2 diabetes pharmacotherapy, long-term use of semaglutide may have a side effect in the form of muscle loss, especially in patients with initial signs of sarcopenia and elderly people. Despite the clinical efficacy of GLP-1 RA, their effect on the exocrine function of the pancreas and a possible association with acute pancreatitis are of concern. Establishing cause-and-effect relationships is critical for patient safety, especially with risk factors. Conclusion. A comprehensive assessment of the balance of benefits and risks of long-term use of glucagon-like peptide-1 receptor agonists, establishing cause-and-effect relationships, and optimizing therapeutic approaches, especially in patients with concomitant risk factors, is critically important for improving patient safety and ensuring maximum benefit from this group of drugs.

  • Open Access

    MULTIFACTORIALITY OF ALZHEIMER’S DISEASE: SCIENTIFIC AND SOCIO-ECONOMIC DIMENSION

    by S. I. Semenenko, I. O. Doroshkevych, A. O. Zhamba, O. M. Semenenko, I. V. Oleksiienko, I. V. Prolygina

    The growth of the proportion of elderly people in the population leads to the globalization of Alzheimer’s disease (AD), which is becoming not only a medical but also a serious social, ethical and economic problem of our time. The aim of the study is a comprehensive analysis of the multifactorial nature of AD, taking into account the interaction of genetic, molecular, metabolic factors, as well as a generalization of modern approaches to early diagnosis and treatment of the disease and an assessment of its medical, social and economic impact on society, the healthcare system and patients’ families. The study was conducted in the format of a systematic review of scientific literature using the following sources: PubMed, Scopus, Web of Science and reports of international organizations for the period 2015–2026. As a result of the analysis of modern scientific data, it was established that today there are a number of pathogenetic theories of the development of AD, among which the leading ones are amyloid, tau-protein, glutamatergic, mitochondrial, metabolic and genetic hypotheses, as well as concepts related to oxidative stress and neuroinflammation. The key links of the neurodegenerative process are the accumulation of β-amyloid, pathological hyperphosphorylation of tau-protein, disruption of proteostasis, autophagy and mitophagy, which leads to destabilization of the neuronal cytoskeleton, formation of neurofibrillary tangles, synaptic dysfunction and neuronal death. Neurodegenerative changes are accompanied by disruption of cellular homeostasis and progressive damage of axons, dendrites and synapses, that justifies the need for early implementation of preventive and neuroprotective strategies to slow down the progression of the disease. At the same time, current pharmacotherapeutic approaches to the treatment of AD are mainly symptomatic and aimed at slowing down the progression of cognitive, behavioral and mental manifestations of dementia. Socio-economic analysis has revealed a significant burden on state budgets and families due to direct medical costs, loss of caregivers’ working capacity and a projected increase in costs in the coming decades. Thus, AD is a classic example of a multifactorial pathology that requires an integrated scientific and social approach.

  • Open Access

    Modern views on therapy with antidepressants on the background of their individual pharmacogenetics

    by O. O. Yakovleva, S. I. Semenenko, N. V. Shcherbeniuk, А. О. Zhamba

    Annotation. In conducting pharmacotherapy, it is necessary to consider the genetic polymorphism of cytochromes P450, especially when receiving an inadequate response to treatment. Martial law in Ukraine contributed to an increase in the use of antidepressants. When prescribing antidepressants, the genetic polymorphism of their metabolism should be taken into account. The aim of the review is a generalization of modern international ideas regarding the selection, appointment, effectiveness control, and safety forecast in the pharmacotherapy of depressive states with antidepressants of different groups. An analytical search was conducted in international information sources and PubMed scientific database regarding the peculiarities of the use of antidepressants in various categories of patients. The review presents the results of the study of genetic polymorphism of cytochrome P450 in pregnant women and different age groups, they also differ in different countries, especially when using certain groups of antidepressants, which have differences in metabolism due to the effects of cytochrome P450. During pharmacogenomic testing (PGx), it is desirable to take into account the presence of slow, intermediate, normal, fast, and ultrafast types of metabolizes CYP2D6 and CYRS19. Selective serotonin reuptake inhibitors were used as first-line therapy in studies of pregnant women. Metabolism of paroxetine is carried out mainly by CYR2D6, citalopram, escitalopram, and certralin - CYR2C19 enzymes. It is known that pregnancy can increase the activity of CYR2D6 by 25-200%, and CYR2C19, on the contrary, decreases it by 50%. Assessment of the rate of metabolism of antidepressants against the background of slow or intermediate allelic variants of the cytochrome P450 genotype can increase the risks of toxicity of their use. Clarification of these problems remains a promising direction of future analysis in relevant populations, against the background of various physiological states of the body and differences in the course of depression.

  • Open Access

    Prospects for the development of higher medical education in the conditions of war and pandemics

    by S. I. Semenenko, L. A. Vozniuk, A. I. Semenenko, I. O. Doroshkevych, N. O. Semenenko, A. O. Zhamba, O. M. Semenenko, I. V. Oleksiienko

    Annotation. The state of higher medical education in today's conditions has undergone significant changes. The use of distance education with the involvement of modern information capabilities as an alternative to the traditional learning process has shown itself positively in the context of pandemics and full-scale Russian military aggression. But the use of such learning elements specifically among medical students has caused controversy due to the idea that in order to acquire knowledge and practical skills, physicians need to be personally present in classrooms for learning and practice. Therefore, the purpose of the article was to analyze the system of theoretical, methodological and anxiological attitudes of the development of higher medical education in the conditions of modern challenges. General scientific and theoretical pedagogical methods of research were used in order to implement the set tasks. A comprehensive analysis of the problem of organizing the training of future doctors was performed using innovative methods of organizing the educational process. In addition, the role of the teacher in today's conditions is highlighted. An analysis of the use of modern teaching methods was carried out STEM education: quest-task, training, case study. Conclusions were made regarding the comprehensive use of modern teaching methods, as this will have an impact on the formation of the level of theoretical and practical knowledge. Attention is drawn to aspects of further transformation of higher medical education in Ukraine.